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Critically appraising the available evidence on management of pelvic pain symptoms associated 29 
with severe endometriosis with the aim of formulating therapeutic indications in individual patients, 30 
may reveal difficult even for skilled professionals, given the discouraging dearth of comparative 31 
effectiveness research in this field. When deciding between surgical or medical treatment for deep 32 
lesions, doubts may arise also because no consensus exists amid those experts who favor either one 33 
or the other option.  34 
1. What type of evidence to inform surgical decisions in women with severe endometriosis? 35 
 The quality of the data regarding the outcomes of surgery for endometriosis seems particularly 36 
poor. Authoritative experts maintain that even the few surgical randomized, controlled trials (RCTs) 37 
conducted on women with endometriosis have methodological shortcomings that limit the validity 38 
of the observed results (1). These authors also emphasize that the efficacy demonstrated in highly 39 
selected participants under strictly controlled conditions, may not systematically translate into 40 
equivalent effectiveness when the same interventions are applied to the general endometriosis 41 
patient population in everyday practice.  42 
 Owing to the difficulties that nowadays render the planning and conduction of surgical 43 
RCTs in endometriosis rather cumbersome, Koninckx et al. conclude that, when dealing with 44 
severe, deep forms, a practical solution already at hand would be relying on "the pool of a 45 
consensus-opinion of the world wide community of (expert) surgeons" that "should be given a much 46 
more important ranking than ‘ideas and opinions’ in the pyramid of evidence of EBM [evidence-47 
based medicine], and this should be reflected in our guidelines" (1). 48 
 However, it might be argued that precisely because no robust evidence defining the 49 
outcomes of surgery for deep endometriosis is available, physicians and patients should not rely on 50 
an opinion, even when it stems from a consensus of experts. Moreover, the issue here is not only 51 
“how” to perform surgery for these difficult disease forms, but also, and no less importantly, 52 
“when” to undertake surgery. Lowering or raising the bar for indicating surgery should contemplate 53 
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not only a precise estimate of its potential benefits and harms in different clinical conditions, but 54 
also an adequate knowledge of treatment alternatives.  55 
 Is a reliable demonstration available on the validity of the consensus-opinion of expert 56 
surgeons in terms of in-depth knowledge of the potential role of medical therapy in women with 57 
deep endometriosis? In this regard, it has been considered that "excellent speakers have promoted 58 
the efficacy of hormone treatments without knowing the benefits of surgical approaches; talented 59 
surgeons are explaining the benefits of a radical removal of lesions without any experience with the 60 
medical treatment options" (2).  61 
2. Intellectual and financial conflicts of interest underpinning therapeutic contrapositions 62 
The question here is whether relying solely on the opinion of expert surgeons, however widespread 63 
and shared, may ensure therapeutic equipoise. The same problem would arise in case only experts 64 
in medical therapy would express their consensus-opinion on the management of deep 65 
endometriosis. Would the common view of same-faction experts, just because is the results of 66 
exchange of information and comparison of experience, lead per se to a balanced and truly patient-67 
centered treatment approach, or would heard mentality among the endometriosis community lead us 68 
astray?  69 
 When debating the role of medical and surgical treatment for endometriosis, Pellicer and 70 
Zupi warn against both intellectual and financial conflicts of interest (COIs), which may influence 71 
the audience of a conference or readers of clinical educational articles. They consider that biased 72 
speakers and authors are prone to attempting to convince colleagues to follow their suggestions (2). 73 
Personal and public gratification of surgeons performing technically demanding procedures may 74 
constitute a driver of the tendency toward approaching lesions only mechanically instead of 75 
pharmacologically. Also working in a fee-for-service healthcare system may well skew therapeutic 76 
indications towards surgery (3). In addition, administrators may boost complex or high-tech 77 
procedures, such as colorectal resection or robotic surgery, with the objective of increasing hospital 78 
revenues.  79 
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 Transfer of money from industries to key opinion leaders may similarly influence the 80 
position of experts fostering new and costly medical therapies for endometriosis. Moreover, 81 
manufacturers of surgical devices and instrumentation as well as pharmaceutical companies, offer 82 
financial support to individual investigators, scientific societies, and congress organizers on a 83 
regular basis (4-6). In such an environment, straight implementation of consensus-opinions of 84 
experts into guidelines independently of the quality of the evidence on which such consensus-85 
opinions are based (1), appears problematic and should be considered with great caution. 86 
 3. Epidemiological and clinical analogies between severe endometriosis and severe 87 
gastroesophageal reflux disease (GERD) 88 
 Reasoning on how the medical community at large behaves when dealing with other clinical 89 
conditions showing similarities with deep endometriosis, may help understand what can be 90 
reasonably expected by medical and surgical treatment, and may facilitate the achievement of a 91 
consensus on management of deep endometriosis. One such condition is severe erosive GERD. 92 
 The prevalence of GERD and endometriosis is high, as both diseases affect approximately 93 
10% of adult females (7). Both conditions have a chronic clinical course and greatly impact on 94 
health-related quality of life. Symptoms are associated with organic lesions, such as erosive 95 
esophagitis with large mucosal breaks extending between mucosal folds in the former case, and 96 
nodules infiltrating the vagina, rectum, and parametria in the latter case. If left untreated, organic 97 
lesions may progress, causing, respectively, esophageal strictures and Barrett esophagus, and 98 
colorectal and ureteral stenosis. Patients with severe erosive GERD and those with severe 99 
infiltrating endometriosis have only two treatment options, take medications indefinitely (proton 100 
pump inhibitors (PPIs); hypoestrogenizing hormonal drugs) or undergo surgery (Nissen antireflux 101 
fundoplication, diaphragmatic hiatoplasty and fundopexy; resection of rectovaginal plaques and 102 
uterosacral ligaments, segmental colorectal resection). Medical therapy is effective in about two 103 
thirds of patients with both severe disease forms (8-10), although it is definitively curative in neither 104 
of them. In fact, disease-specific symptoms return quickly and severely in most cases if drugs are 105 
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discontinued (8-10). Adverse effects of PPIs are common but generally minor, as are those 106 
associated with progestins. The complications of long-term PPIs use are not completely defined, but 107 
potentially important, including increased risks for various types of infections, chronic kidney 108 
disease, and bone fractures. Long-term progestin use is associated with a slightly increased risk of 109 
breast cancer. The effects on serum lipid profile and bone mineral content vary depending on the 110 
type of progestin used. In both conditions surgical procedures can be performed at laparoscopy with 111 
reduction of morbidity and costs. The incidence of severe intra- and immediate post-operative 112 
complications is similar (fundoplication, 4-5%: infection, bleeding, esophageal perforation; deep 113 
endometriosis excision, 5%: neurogenic bladder atony, rectovaginal fistula formation, pelvic 114 
abscess, ureteral injury). Long-term surgical sequelae are relatively frequent after fundoplication 115 
(dysphagia, gas bloating) and rare after surgery for deep endometriosis (motor paralytic bladder, 116 
stenosis of bowel anastomosis). The 5-year postoperative symptom recurrence rate is between 20 117 
and 30% after fundoplication (7,9), and between 40 and 50% after resection of infiltrating 118 
endometriotic lesions (11,12). The proportion of patients needing long-term medical therapy despite 119 
previous surgical treatment is high, being between 20 and 40% after fundoplication (7,9,10), and 20 120 
and 50% after endometriosis resection (11-13). The proportion of patients undergoing second-line 121 
surgery is about 20% after both procedures, and the complication rate at secondary surgery is 122 
similarly increased compared with primary surgery after both fundoplication and endometriosis 123 
resection (7,9,11,12). The oncological risk is moderately increased if severe GERD is left untreated 124 
(esophageal adenocarcinoma), and slightly increased if severe endometriosis is left untreated (type I 125 
epithelial ovarian cancers). 126 
4. Differences in management approaches to severe endometriosis and severe GERD 127 
Despite the close similarities between severe GERD and severe endometriosis, recognized 128 
authorities in the respective fields tend to behave differently when considering treatments. Experts 129 
of GERD acknowledge that PPIs, without surgery, must be taken for decades. The symptomatic and 130 
not curative nature of PPIs is not considered equal to "inefficacy", and undertaking surgery is 131 
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deemed a choice in patients unwilling to take PPIs for life, or as a second-line therapeutic option 132 
when PPIs do not relieve symptoms during treatment (7,10). Some expert endometriosis surgeons 133 
do not contemplate that progestins, without surgery, should be taken for years or until pregnancy is 134 
desired, and dismiss these medications as ineffective or temporary because symptoms recur after 135 
treatment (14).  136 
 Large cohort studies and RCTs have been conducted on the effect of fundoplication for 137 
GERD, whereas mostly retrospective case series are available to assess the effect of excisional 138 
surgery for deep endometriosis. In the latter case, the risks of bias are not limited to recall bias, but 139 
include selection bias, reporting bias, and publication bias. It is an epidemiological tenet that non-140 
comparative studies tend to systematically overemphasize the effect of medical interventions. 141 
Despite the limited strength of the evidence supporting surgery for infiltrating lesions, many expert 142 
endometriosis surgeons foster excisional treatment anyway, sometime maintaining at conferences 143 
that radical extirpation of lesions is curative. Unfortunately, as in the case of surgery for GERD, 144 
quite frequently it is not (11-13). Moreover, it is often difficult to discriminate how much of the 145 
effect is due to surgery and how much to postoperative medical therapy (11).  146 
 Despite the fact that surgery for GERD is supported by evidence of much higher quality 147 
with respect to surgery for deep endometriosis, surgeons experts of GERD do not seem to consider 148 
laparoscopy as the first or the only reasonable option. As an example, Maret-Ouda et al. maintain 149 
that "laparoscopic antireflux surgery with fundoplication is a treatment alternative in patients with 150 
inadequate response to pharmacological treatment" (7). 151 
 But the difference that strikes most between expert of GERD and expert of endometriosis, 152 
regards the consideration of the patient’s role. According to Spechler,"whether the greater than 153 
80% possibility of long-term freedom from PPIs and their associated risks warrants the 4% risk of 154 
acute surgical complications and the 17.7% risk of GERD recurrence is a decision that individual 155 
patients should make after a detailed discussion of these risks and benefits with their physicians. 156 
Vercellini et al.,  8 
There are wide variations among individuals in how they perceive and deal with different risks, and 157 
those factors should play a major role in guiding management choices" (10).  158 
 In other words, the main issue here is not how the physician should choose between the two 159 
treatment options, but how the physician should advise patients in order to allow them to take 160 
informed decisions. There is matter for reflection.  161 
5. Patient centeredness is the way to overcome contrapositions 162 
Paternalistic medicine (that is, the doctor knows what is best for the patient) seems to underpin the 163 
contraposition between the experts of surgery and those of medical treatment in the endometriosis 164 
field. If this is true, patient engagement does not appear to be a priority when deciding how to treat 165 
a woman with a symptomatic deep form. Both experts should begin to put aside their preferences, 166 
move toward a cultural change, and truly embrace patient-centered medicine (that is, informed 167 
women know what is best for them based on their priorities and preferences).  168 
 Patients should receive a complete, detailed, and balanced counseling on advantages and 169 
disadvantages of medical and surgical options for the treatment of pain associated with deep 170 
endometriosis. Data should be provided in a plain and easily comprehensible manner, using crude 171 
percentages and decision aids. The woman, and no one else in her place, should take the final 172 
decision, being aware that the main therapeutic objective is improving health-related quality of life, 173 
and that this may or may not necessitate radical removal of lesions. 174 
 According to Victor Montori, the answers to what is best for the patients and their families 175 
are complicated for at least three reasons (http://www.mayo.edu/research/labs/knowledge-176 
evaluation-research-unit/overview. Accessed on September 23, 2017).  177 
 Firstly, the evidence regarding different treatment options may be incomplete, biased, 178 
imprecise, irrelevant, or inconsistent. This seems to be the case in the endometriosis area, and 179 
adequately designed, comparative effectiveness research is badly needed (3). In the meantime, the 180 
recent guideline issued by the National Institute for Health and Care Excellence could be used, as it 181 
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appears comprehensive, detailed, and based on a systematic and critical literature review. Moreover, 182 
aspects of cost-effectiveness are considered analytically for the first time (15).  183 
 Secondly, what is best is not an absolute notion, but depends on individual values and, given 184 
the options, what issues are more salient to personal goals for health and health care. The shared 185 
decision-making approach should here guide the patient-physician dyad.  186 
 Thirdly, what is best depends also on the inter-personal situation, in relation to family, job, 187 
community, and life at large. According to the International Minimally Disruptive Medicine 188 
Workgroup, patients affected by chronic diseases must face not only the burden of illness (e.g., 189 
symptoms and fatigue), but also the burden of treatment (e.g., visits to the physician, various types 190 
of tests, drug intake, self-monitoring, lifestyle changes, administrative tasks to access and 191 
coordinate care) (16). Hidden costs, full or part payment of treatments, and the potential 192 
psychosocial burden of being excessively medicalized also should be considered (16). 193 
 The "value" of any given intervention for endometriosis is the balance between potential 194 
benefits, potential harms, and costs, combined with personal patient preferences (3). According to 195 
Spencer-Bonilla et al. (16), "ultimately, the value of care for patients should reflect the health 196 
outcomes achieved and the degree of burden that patients and their caregivers must bear to achieve 197 
those outcomes". Organizing high-quality, high-value, patient-centered endometriosis care requires 198 
awareness of both, the burden of illness and the burden treatment, and this should become the 199 
common objective of all endometriosis experts, independently of their specific expertise.  200 
6. War is over (if you want it)† 201 
†Lennon J and Ono Y. From: Sometimes in New York City, UK, Apple Records, 1972. 202 
The divergence of position of experts of surgery and experts of medical therapy does not benefit 203 
patients with severe endometriosis and does not improve outcomes, as women may be deprived of 204 
the potential benefits of the alternative option.  205 
 Ideally, physicians should be in the condition to offer both treatments. A written summary 206 
including the number and type of surgical procedures performed for severe endometriosis on an 207 
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annual basis, together with the number of main complications observed, would add important 208 
information and would allow women to decide whether undertake surgery in that center or ask for 209 
further consultations elsewhere. In case the woman decides for surgical treatment and adequate 210 
expertise is not available locally, the physician has the ethical duty to refer that patient to colleagues 211 
with sufficient technical capabilities, with the objective of maximizing the benefits and minimize 212 
the harms of the procedure. Likewise, surgeons with limited experience in hormonal therapy should 213 
refer those patients opting for long-term medical management to centers with specific expertise, in 214 
order to plan the best individual therapeutic scheme in terms of efficacy, tolerability, risks, and 215 
costs.  216 
 Experts on both sides should understand that collaboration, instead of confrontation, could 217 
pave the way toward improved patient care, acknowledging that some conditions might be 218 
amenable to hormonal manipulation and other to excision. Surgical and medical treatments may 219 
also be combined, thus potentially achieving an additive effect. This approach has the potential to 220 
improve outcomes, the only meaningful objective of gynecologists caring for women with 221 
endometriosis. 222 
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